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Souhrn 
Lidská žaludeční šťáva obsahuje zejména aspartátové proteasy - pepsin A a 
pepsin C. Oba pepsiny jsou produkovány v žaludeční sliznici jako inaktivní 
pepsinogeny (pepsinogen A a pepsinogen C), které se liší svými fyzikálně-
chemickými a imunologickými vlastnostmi. Oba pepsinogeny  obsahují několik 
izozymogenů. K aktivaci pepsinogenů na příslušné pepsiny dochází v kyselém 
prostředí žaludku. 
Hladiny pepsinogenů v krevním séru odrážejí morfologický a funkční stav 
žaludeční sliznice. Již mnoho let je pozorována souvislost mezi hladinami 
lidských pepsinogenů a některými žaludečními onemocněními (např. rakovinou 
žaludku, gastritidou). Z diagnostického hlediska je významný především 
vzájemný poměr pepsinogenu A a pepsinogenu C nejen v žaludeční sliznici, ale 
také v krevním séru. Pacienti s rakovinou žaludku nebo s atrofickou gastritidou 
mají významně snížený poměr pepsinogenu A a pepsinogenu C v krevním séru 
oproti zdravým jedincům. Během žaludečních onemocnění dochází také ke 
změnám zastoupení jednotlivých izozymogenů. Určení těchto změn by proto 
mohlo být významné pro včasnou diagnostiku zmíněných onemocnění. 
Téma dizertační práce je součástí projektu zabývajícího se zejména 
vypracováním metody pro separaci žaludečních aspartátových proteas, která by 
byla vhodná pro sledování jejich změn během zmíněných onemocnění. 
Dizertační práce se konkrétně zabývala přípravou vhodných afinitních sorbentů 
pro separaci pepsinů a pepsinogenů. Při výběru vhodného afinitního ligandu 
pro tyto proteasy jsme vycházeli ze známého substrátu N-acetyl-L-fenylalanyl-
3,5-dijod-L-tyrosinu, pomocí kterého lze stanovit aktivitu pepsinu A ve směsi 
s pepsinem C. Byly připraveny tři afinitní sorbenty: jodovaná L-tyrosin-
Sepharosa, 3,5-dijod-L-tyrosin-Sepharosa a N-acetyl-L-fenylalanin-Sepharosa. 
Připravené sorbenty byly charakterizovány pomocí modelového enzymu 
(prasečího pepsinu A). Při studiu interakce prasečího pepsinu A a jeho 
komplexu s pepstatinem A s připravenými sorbenty bylo prokázáno, že se 
aktivní místo enzymu nepodílí na jeho interakci s těmito sorbenty. Dále byla 
prokázána účast fosfátové skupiny v molekule pepsinu na jeho interakci 
s N-acetyl-L-fenylalanin-Sepharosou. Všechny připravené sorbenty byly 
použity k separaci pepsinu A a pepsinu C z okyseleného homogenátu lidské 
žaludeční sliznice pacientů s různými žaludečními chorobami, případně 
žaludeční šťávy zdravého jedince. Výsledky ukázaly, že nejvhodnějším 
sorbentem pro separaci pepsinů je N-acetyl-L-fenylalanin-Sepharosa. Pomocí 
tohoto sorbentu se také podařilo částečně separovat jeden z izozymogenů 
pepsinogenu A z lidské žaludeční sliznice. 
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Summary 
Human gastric juice contains mainly aspartic proteases - pepsin A and 
pepsin C. Both pepsins are produced by gastric mucosa as inactive pepsinogens 
(pepsinogen A and pepsinogen C) that differ in their physico-chemical and 
immunological properties. Both pepsinogens consist of molecular variants, 
isozymogens. Pepsinogens are activated to the corresponding pepsins in the 
acidic environment of the gastric lumen. 
The levels of pepsinogens in serum reflect the morphological and 
functional status of gastric mucosa. The levels of pepsinogens are associated 
with gastric diseases (e.g. gastric cancer, gastritis). For a diagnostic purpose, 
the ratio of pepsinogen A to pepsinogen C not only in the gastric mucosa but 
also in serum is relevant. The gastric cancer patients or the atrophic gastritis 
patients have significantly lower ratio of serum pepsinogen A to pepsinogen C 
in comparison with the healthy subjects. In addition, proportion of individual 
isozymogens reflects the type of the gastric disease. Determination of changes 
in pepsinogen levels could be useful for early diagnostics of gastric diseases 
mentioned above. 
A subject of this Ph.D. thesis is a part of a long-term investigation that 
focuses on the elaboration of methods for the separation of gastric aspartic 
proteases that would be suitable for monitoring of their changes in mentioned 
diseases. This thesis was mainly focused on preparation of affinity sorbents 
suitable for separation of pepsins and pepsinogens. The choice of ligands was 
based on the substrate N-acetyl-L-phenylalanyl-3,5-diiodo-L-tyrosine that is 
used to differentiate pepsin A and pepsin C. The following three affinity 
sorbents were prepared: iodinated L-tyrosine-Sepharose, 3,5-diiodo-L-tyrosine-
Sepharose, and N-acetyl-L-phenylalanine-Sepharose. The basic characteristics 
of the prepared affinity sorbents were determined using the model enzyme 
(porcine pepsin A). The comparison of the chromatographic behavior of 
porcine pepsin A and its complex with pepstatine A showed that the enzyme 
active site was not involved in the enzyme interaction with ligands. In addition, 
participation of a phosphate group of the pepsin molecule was proved in the 
interaction of porcine pepsin A with N-acetyl-L-phenylalanine-Sepharose. All 
prepared sorbents were used for the separation of human pepsin A and pepsin C 
from acidified extract of gastric mucosa of patients with various types of 
diseases, eventually from gastric juice of healthy subjects.  Out of the prepared 
sorbents, N-acetyl-L-phenylalanine-Sepharose was found to be the most 
suitable for this purpose. In addition, one of the isozymogens of pepsinogen A 
from gastric human mucosa was partially separated using this sorbent. 
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1. Introduction 
The human gastric juice contains two major groups of aspartic proteases: 
pepsin A (EC 3.4.23.1) and pepsin C (3.4.23.3). Pepsins are endopeptidases 
which attack native proteins at acidic pH (ref. 1); maximally active around 
pH 2.0 - 2.3, as determined using hemoglobin as the substrate 2. The 
denaturation of protein substrates at low pH has been shown to contribute to 
their efficient hydrolysis 3. Pepsin A specifically cleaves peptide bonds 
involving especially hydrophobic and aromatic amino acids 1, 3, 4 . Pepsin C 
preferentially cleaves Tyr-Xaa bonds (Xaa - various amino acids) 3. Different 
synthetic peptides have been tested as substrates for pepsin A and pepsin C 5  - 8. 
N-acetyl-L-phenylalanyl-3,5-diiodo-L-tyrosine is the substrate for 
differentiation of pepsin A and pepsin C 3, 9. 
Members of the family of aspartic proteases are inhibited by synthetic 
inhibitors diazoacetyl norleucine methylester and 1,2-epoxy-3-(p-nitrophenoxy) 
propane, and by a native inhibitor - pepstatin A 1. The potency of these 
inhibitors varies for different aspartic proteases 2, 10. The inhibition of pepsins 
by these two synthetic inhibitors is irreversible 1.  Pepstatin A was isolated 
from culture filtrates of various Streptomyces 11. Pepstatin A is a 
heptapeptide 12 that non-covalently interacts with the active site of pepsin and 
thus it blocks the accessibility of a substrate to the active site.1, 13, 14 
Pepsin A and pepsin C are secreted as inactive zymogens, pepsinogen A 
(PGA) and pepsinogen C (PGC), in the gastric mucosa. PGA is produced by 
cells of the gastric body and fundus, while PGC production was found 
throughout the stomach (the cardia, the fundus, the body and the antrum). In 
addition, PGC was found also in the proximal duodenum and in prostate 1, 15. 
PGC is completely reabsorbed and metabolized by the kidneys. On the other 
hand, the kidneys metabolize only two-thirds of PGA. Both PGA and PGC can 
be detected in the blood, but only PGA is present under the physiological 
conditions in the urine 15. 
Both PGA and PGC consist of isozymogens that differ in net charge, 
molecular weight or both 16, 17. Seven isozymogens of pepsinogens were found 
in human gastric mucosa using the non-denaturing agar gel electrophoresis with 
stanining for proteolytic activity. They were designated Pg1 to Pg7 according 
to their decreasing anodal mobility. PGA consists of five isozymogens, 
Pg1 − Pg5, whereas PGC consists of two isozymogens, Pg6 – Pg7 (ref. 17). 
The levels of both pepsinogens in serum reflect the morphological and 
functional status of gastric mucosa; changes in pepsinogen levels are associated 
with gastric diseases 18 - 20. Therefore, pepsinogens and their active forms are of 
a great medical and pharmaceutical interest. In healthy subject, the serum levels 
of pepsinogens are relatively constant but they considerably vary between 
different individuals. These variations are due to, i.e. age 20 - 22, sex 21, 22, diet, 
and nationality 15. In fact, the PGA and PGC ratio could be considered more 
important than absolute values of PGA and PGC levels for diagnostic purposes. 
 7
Serum PGA levels and the ratio PGA/PGC significantly decreased in both 
the atrophic gastritis patients and gastric cancer patients as compared with the 
healthy controls, the gastric ulcer patients and the duodenal ulcer patients. 
Serum PGA levels and the ratio PGA/PGC in the atrophic gastritis patients 
were linked with the site and the grade of atrophic gastritis; it decreased with 
the progression of atrophic process 18. Serum PGA levels were significantly 
higher in duodenal ulcer 20, 23 and gastric ulcer 20 patients, and significantly 
lower in the gastric cancer patients 18, 20 compared to the healthy controls. 
Serum PGC levels were higher in the duodenal ulcer or gastric ulcer 
patients 20, 21, whereas either no significant difference 20 or significantly 
higher 21, 24 PGC levels were found in the gastric cancer patients in comparison 
with the healthy controls. The ratio of PGA/PGC was significantly higher in the 
duodenal ulcer patients 20 but significantly lower in the gastric cancer 
patients 18, 20, 21, 24 compared to the healthy controls. In addition, PGA values 
were significantly lower in patients with advanced gastric cancer than in 
patients with early stage of gastric cancer 18, 20. Levels of pepsinogens reflect 
also the cancer tissue type; both serum PGA and PGC levels were found to be 
significantly lower in intestinal-type cancer than in diffuse-type cancer. 
However, regardless the histological type, the ratio PGA/PGC was significantly 
lower in the gastric cancer patients in comparison with the healthy controls 24.  
The presence and levels of isozymogens Pg3 to Pg5 also reflect the type of 
various gastric diseases. The patients with ulcer disease have the Pg3 to Pg5 
ratio higher than 1, while gastric cancer patients lower than 1. In addition, the 
gastric cancer patients have significantly higher concentration of Pg5 (ref. 19). 
In clinical practice, the serum concentrations of PGA and PGC are 
determined by immunochemical methods (e.g. ELISA*), which utilize different 
immunochemical properties of these pepsinogens. Currently, many 
immunochemical kits for the determination of both pepsinogens in serum are 
available 25, 26.  
No simple one-step chromatographic technique has been found yet for the 
isolation and separation of human pepsins and their zymogens. To obtain 
individual pepsins or their zymogens, or even individual isozymogens, by 
chromatographic methods, a multi-step chromatography has been required 27-32.  
Affinity chromatography represents a valuable tool for the purification of 
proteins, for the separation of various proteins differing only slightly in their 
properties, and for the studies on structure of proteins or enzyme active site. 
This technique is based on the unique ability of biologically active substances 
to specifically and reversibly bind to a complementary substance (ligand), 
immobilized by a covalent bond to inert matrix. The choice of a suitable ligand 
is evidently the most important factor in the successful application of this 
technique. However, other components also influence the affinity separation, 
e.g. nature of matrix, matrix activation, spacer arm properties, mechanism of 
                                                 
* „enzyme linked immunosorbent assay“ 
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ligand coupling, etc.33 Only a limited number of ligands were described for the 
separation of pepsins, e.g. antibodies 30, 31, inhibitors 32, 34 - 36 and derivatives of 
substrate. Immobilized ligands belonging to the last group are derived from the 
substrate – N-acetyl-L-phenylalanyl-3,5-diiodo-L-tyrosine 3, 9 used for 
distinguishing pepsin A and pepsin C; the following ligands were derived: 
L-phenylalanine, L-tyrosine, their iodinated analogs,  and N-acetyl-L-
phenylalanine. The affinity of pepsins and pepsinogens to these ligands was 
influenced by iodine content and the manner of ligand coupling 37 - 42. 
Besides chromatography, electromigration methods have been used for 
separation of human pepsinogens and pepsins, e.g. non-denaturing 
polyacrylamide 16 or agar 17 gel electrophoresis, and isoelectric focusing 43, 44. 
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2. Aim of the Thesis 
The object of this thesis forms a part of a long-term investigation that 
focuses on a study of a relationship between gastric diseases and changes in 
abundance of individual aspartic proteases in human gastric juice and their 
zymogens in gastric mucosa. The estimation of pepsinogen A and 
pepsinogen C ratio belongs to an important step in diagnosis of pre-malignant 
state of gastric cancer. 
Aim of this thesis was to prepare the suitable affinity sorbent for the 
separation of human gastric aspartic proteases (pepsins) and their zymogens 
(pepsinogens). The solution of this task was separated in the following steps: 
  
• Preparation of affinity sorbents for the separation of human pepsins 
and pepsinogens and finding of the optimum conditions for their 
adsorption and elution. 
 
• Characterization of basic parameters of the prepared affinity sorbents 
using model protease – porcine pepsin A. 
 
• Study of porcine pepsin A separation and the participation of the 
enzyme active site in its interaction with affinity sorbents. 
  
• Application of the prepared affinity sorbents for the separation of 
human pepsins and pepsinogens from human gastric juice and human 
gastric mucosa, respectively. 
 
 
 10
3. Materials and Methods 
 
Materials 
• Biologic samples: lyophilized human gastric juice obtained from healthy 
subject, extracts of human gastric mucosa obtained from resected stomach 
of patients with gastric diseases, extracts of rat gastric mucosa  
• Model proteins: porcine pepsin A (EC 3.4.23.1), porcine pepsinogen A, 
trypsin (EC 3.4.21.4) from bovine pancreas, α-chymotrypsin (EC 3.4.21.1) 
from bovine pancreas, chicken ovalbumin, bovine serum albumin (all from 
Sigma-Aldrich, Czech Republic) 
• Sepharose 4B, N-acetyl-L-phenylalanine, Boc-3,5-diiodo-L-tyrosine, 
L-tyrosine, pepstatin A, acid phosphatase (EC 3.1.3.2) from potato (all 
from Sigma-Aldrich, Czech Republic); monoclonal antibody againts 
pepsinogen A and monoclonal antibody against pepsinogen C (Medix 
Biochemica, Finland) 
 
Preparation of affinity sorbents 
• L-tyrosin was directly coupled to the divinyl sulfone-activated 
Sepharose 4B. Immobilized L-tyrosine was iodinated after coupling 40. 
• For the immobilization of N-acetyl-L-phenylalanine and 3,5-diiodo-
L-tyrosine with protected amino group (Boc)*, ethylene diamine was first 
coupled to divinyl sulfone activated Sepharose 4B. Afterwards, the ligands 
were linked using a carbodiimide reaction. Then the protective group was 
removed from Boc-3,5-diiodo-L-tyrosine-Sepharose 4B (ref. 41).  
 
Affinity chromatography of proteins 
• performed using: FPLC System (Ecom, Czech Republic) or BioLogic 
DuoFlow System (Bio-Rad, USA). 
• the Bio-Scale MT2 High-Resolution Column (52 mm × 7 mm i.d.; Bio-
Rad, USA) was packed with the prepared affinity sorbents 
• general protocol for protein analysis: (1) equilibration with the starting 
buffer; (2) protein loading (1 ml); (3) washing out non-adsorbed substances 
with the starting buffer; (4) elution of protein with the eluting buffer (linear 
gradient or isocratic); flow rate: 1 ml/min; collected 1 ml fractions 
• different buffers and solutions were tested to maximize protein recovery 
and achieve the best separation of proteins 
• in collected fraction protein content and proteolytic activity of pepsin were 
determined 
                                                 
* Boc – tert – butyloxycarbonyl 
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• identification of separated proteins was performed using 
MALDI-TOF/TOF MS* or non-denaturing polycrylamide gel 
electrophoresis with staining for proteolytic activity 29 
 
Analytical methods 
• protein concentration was determined using bicinchoninic acid protein 
assay 45 
• proteolytic activity was determined by modified Anson and Mirsky 
method 46 
• phosphorus content in pepsin was determined by „Phosphoprotein 
Phosphate Estimation Assay Kit” (Pierce, USA) 
 
 
                                                 
* MALDI-TOF/TOF MS – matrix assisted laser desorption ionization - time of flight/time of flight 
mass spectrometry 
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4. Results and Discussion  
4.1. Preparation of Affinity Sorbents 
In this study, the choice of ligands was based on a substrate (N-acetyl-L-
phenylalanyl-3,5-diiodo-L-tyrosine) used for the differentiation of pepsin A and 
pepsin C 3, 9. N-acetyl-L-phenylalanine, 3,5-diiodo-L-tyrosine or L-tyrosine 
were immobilized to divinyl sulfone activated Sepharose 4B (ref. 40, 41). 
L-tyrosine was linked to the activated matrix via its free amino group. For the 
immobilization of the other two ligands (that is N-acetyl-L-phenylalanine, 
3,5-diiodo-L-tyrosine with protected amino group) via their free carboxyl 
groups, ethylene diamine was first coupled to divinyl sulfone activated 
Sepharose 4B. Afterwards, the ligands were linked using a carbodiimide 
reaction. After the immobilization of the aromatic amino acid derivatives, 
L-tyrosine-Sepharose 4B was further modified by iodination performed via the 
standard chloramine method, and Boc-3,5-diiodo-L-tyrosine-Sepharose* 4B 
was hydrolyzed to remove the Boc protective group. 
Previous studies showed that the pepsin interactions with ligands derived 
from aromatic amino acids depended on the manner of coupling 40, 41. The other 
factor that affects the affinity of aspartic proteases to aromatic amino acids is 
the presence of iodine atoms in the ligand molecule. The substitution by iodine 
into the phenyl ring of immobilized aromatic amino acids increased their 
affinity for pepsins compared to un-substituted compounds 40. 
Divinyl sulfone** activated Sepharose was found to be a suitable matrix for 
coupling of different ligands 39 - 41. Results of this study showed an 
advantageous application of the divinyl sulfone activated Sepharose for 
a linkage of amino acid derivatives both via their amino and the carboxyl 
groups. In the second case, aromatic amino acid derivatives were coupled to the 
activated matrix via an ethylene diamine spacer arm. In both cases, the amino 
group was coupled with the vinyl group of the divinyl sulfone activated agarose 
matrix. The structure of the resulting affinity sorbents corresponds to the 
general formula of thiophilic sorbents: agarose matrix–O–CH2–CH2–SO2–CH2–
CH2–X–Y (ref. 49). Where X, besides S, can also be O or N and Y is an 
aromatic or heteroaromatic compound. Studies on the use of these thiophilic 
sorbents were mainly directed to the separation of different antibodies from 
various sources 48 - 51. 
 
                                                 
* Boc – tert – butyloxycarbonyl 
** Divinyl sulfone was originally used for  cross-linking of agarose gel 47, 48. 
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4.2. Optimization of Chromatographic Conditions for 
Porcine Pepsin A on Affinity Sorbents 
We focused on investigation of adsorption/desorption conditions for 
porcine pepsin A to/from prepared affinity sorbents. The choice of 
chromatographic conditions was limited by porcine pepsin A inactivation at pH 
higher than 6.0 (ref. 52). We investigated effect of pH, ionic strength (NaCl, 
concentration of mobile phase) and composition of mobile phases (phosphate 
buffer, acetate buffer, MES*) on adsorption/desorption of porcine pepsin A. 
Affinity chromatography of porcine pepsin A under the optimum conditions is 
shown in figure 1. Porcine pepsin A adsorbed to all the prepared affinity 
sorbents, but under different conditions. No protease activity was detected in 
the flow-through fractions. 
The increase in buffer pH was required for the desorption of porcine 
pepsin A from iodinated L-tyrosine–Sepharose (coupled via amino group) 
while the increase in buffer ionic strength released the pepsin from N-acetyl-
L-phenylalanine-Sepharose and 3,5-diiodo-L-tyrosine-Sepharose (both coupled 
via carboxyl groups). The basic characteristics of the prepared affinity sorbents 
for porcine pepsin A were determined (tab. 1). 
 
 
Tab. 1 Comparison of some characteristics of the prepared affinity sorbents 
Characteristics 
N-acetyl-
L-phenylalanine-
Sepharose 
3,5-diiodo-
L-tyrosine-
Sepharose 
Iodinated 
L-tyrosine-
Sepharose 
Reproducibility RSD (%) 2 4 5 
Capacity (mg/ml) 76.5 49.7 41.5 
R2 0.993 0.998 0.999 
Recovery (%) 96 88 96 
Reproducibility – expressed as RSD (relative standard deviation; in percent) of elution peak area 
for ten repeated individual experiments performed under the optimum chromatographic conditions 
for porcine pepsin A; capacity – expressed in mg of porcine pepsin A adsorbed to 1 ml of sorbent; 
R2 - regression coefficient of the linear dependence of the elution peak area on the applied amount 
of porcine pepsin A; recovery – the proteolytic activity of porcine pepsin A desorbed from affinity 
sorbent expressed in percentage of applied porcine pepsin A. 
 
                                                 
* 2-(N-Morpholino)ethanesulfonic acid 
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Fig. 1 Affinity chromatography of porcine pepsin A on affinity sorbents under the optimum 
conditions 
(a) N-acetyl-L-phenylalanine-Sepharose: I – 100 mM acetate buffer, pH 3.7; II – 100 mM acetate 
buffer, pH 3.7, containing 0.5 M NaCl; (b) 3,5-diiodo-L-tyrosine-Sepharose: I – 50 mM acetate 
buffer, pH 6.0; II – 50 mM acetate buffer, pH 6.0, containing 1.0 M NaCl; (c) iodinated L-tyrosine-
Sepharose: I – 25 mM acetate buffer, pH 4.0; II – 50 mM phosphate buffer, pH 6.0, containing 
0.3 M NaCl; sample – 1 ml of porcine pepsin A solution (1mg/ml of starting mobile phase); flow 
rate – 1 ml/min; column graph – proteolytic activity, the enzyme activity determined by the 
modified Anson and Mirsky method; solid line – absorbance measured at 280 nm. 
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4.3. Non-specific Adsorption of Proteins to Affinity Sorbents 
Affinity chromatography is a selective method that has been also 
frequently used for simplification of complex mixtures in proteomics. It is 
based on a reversible specific interaction of proteins present in a sample with an 
affinity ligand immobilized onto a matrix. Any other interactions of proteins 
from a sample, e.g. with matrix or spacer arm, are undesirable. 
The non-specific interactions of the prepared affinity sorbents with various 
types of proteins were compared under the optimum conditions for the 
separation of porcine pepsin A. The behavior of the following proteins besides 
porcine pepsin A was examined: bovine serum albumin (BSA), chicken 
ovalbumin, trypsin and α-chymotrypsin from bovine pancreas. Under the 
conditions used, complete amount of BSA and ovalbumin were retained on 
3,5-diiodo-L-tyrosine-Sepharose and iodinated L-tyrosine-Sepharose. In 
contrast, N-acetyl-L-phenylalanine-Sepharose adsorbed only a low amount of 
these proteins (up to 19%) and therefore it was the most ideal from this point of 
view. 
As was already mentioned, the structure of prepared affinity sorbents 
resembles to N-containing aromatic thiophilic sorbents. Porath and 
Oscarsson 53 suggested that such sorbents are intermediates between thiophilic 
and hydrophobic sorbents. The similarity of our sorbents to these structures 
might explain the observed strong adsorption of bovine serum albumin and 
chicken ovalbumin to some of the prepared sorbents. 
4.4. Study of Porcine Pepsin A Interactions with Affinity 
Sorbents 
4.4.1. Participation of Pepsin Active Site in Its Interactions with 
Sorbents 
 The chromatographic behavior of porcine pepsin A in the presence and 
absence of pepstatin A on the prepared affinity sorbents was compared to get 
more information on interactions of the studied enzyme with all immobilized 
ligands. Pepstatin A is a peptide inhibitor of aspartic proteases, which binds 
tightly to the active site of the enzyme 13, 14. In our experiments, the behavior of 
porcine pepsin A and its complex with pepstatin A on all affinity sorbents was 
the same: the enzyme and the inactive complex were completely adsorbed to 
the affinity sorbents under the conditions used. The results obtained with 
N-acetyl-L-phenylalanine-Sepharose are shown in (fig. 2). This observation 
might indicate that the enzyme active site is not involved in the adsorption of 
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the enzyme to the immobilized ligands. The behavior of pepsin and its complex 
with pepstatin A on immobilized ligands that are based on derivatives of 
aromatic amino acids differs from that of the same enzyme and its complex on 
Phenyl-Sepharose 54 (tab. 2). The complex of porcine pepsin A with pepstatin A 
exhibited reduced binding to Phenyl-Sepharose in comparison with the enzyme 
in the absence of the inhibitor 54. Phenyl-Sepharose is very often used as a 
sorbent for hydrophobic chromatography. 
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Fig. 2 Affinity chromatography of porcine pepsin A on N-acetyl-L-phenylalanine-Sepharose in the 
absence (a) and presence (b) of pepstatin A (inhibitor) 
Chromatographic conditions: I – 100 mM acetate buffer, pH 3.7; II – 100 mM acetate buffer, 
pH 3.7, containing N-acetyl-L-phenylalanine ((1 mg + 2 μl N,N-dimethylformamide)/1 ml); 
III − 100 mM acetate buffer, pH 3.7, containing 0.5 M NaCl; flow rate – 1 ml/min; (a) sample – 
1 ml of porcine pepsin A solution (1 mg/1 ml of 100 mM acetate buffer, pH 3.7; (b) sample – 1 ml 
of mixture solution ((1 mg of porcine pepsin A and 1 mg of pepstatin A)/ml of 100 mM acetate 
buffer, pH 3.7); column graph – proteolytic activity, the enzyme activity determined by the 
modified Anson and Mirsky method; solid line – absorbance measured at 280 nm. 
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 Porcine pepsinogen A was completely adsorbed to N-acetyl-
L-phenylalanine-Sepharose and 3,5-diiodo-L-tyrosine-Sepharose, while it was 
not adsorbed to Phenyl-Sepharose 54. Porcine pepsinogen A consists of the 
prosegment (activation segment) and the pepsin moiety 52, 55. The prosegment 
covers the pepsin active site and prevents entry of the substrate to the active 
site. Therefore, we could suppose that the active site of pepsin does not 
participate in the interaction with the prepared affinity sorbents, whereas it is 
involved in the interaction with Phenyl-Sepharose 54 (tab. 2). Contrary to 
immobilized ligands linked to Sepharose via carboxyl group, only a negligible 
amount of porcine pepsinogen A was adsorbed to iodinated L-tyrosine-
Sepharose under the conditions used (pH 6.0 and pH 6.5). 
The binding of porcine pepsin A to immobilized derivatives of aromatic 
acids was also not influenced by the presence of the corresponding free ligand 
in buffer. Porcine pepsin A was not released with N-acetyl-L-phenylalanine 
solution from N-acetyl-L-phenylalanine-Sepharose (fig. 2). Similarly, 
3,5-diiodo-L-tyrosine solution had no effect on porcine pepsin A adsorbed to 
3,5-diido-L-tyrosine-Sepharose and iodinated L-tyrosine-Sepharose (results not 
shown). 
 
 
Tab. 2 Comparison of chromatographic behavior of porcine pepsin A and pepsinogen A 
on prepared affinity sorbents and Phenyl-Sepharose 54 
Adsorbed protein  
(%) 
Sorbent 
Pepsin A 
Pepsin A 
+ 
pepstatin A 
Pepsinogen 
A 
Ref. 
Phenyl-Sepharose 95 61 0 54 
N-acetyl-L-phenylalanine-
Sepharose 
100 100 100 * 
3,5-diiodo-L-tyrosine-
Sepharose 
100 100 100 * 
Iodinated  L-tyrosine-
Sepharose 
100 100 0 * 
* This work  
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4.4.2. Effect of Porcine Pepsin A Phosphate Group in 
Interactions with N-acetyl-L-phenylalanine-Sepharose 
Porcine pepsin A contains one phosphate group bound on serine residue in 
position 68 (ref. 56). Porcine pepsin A was dephosphorylated by potato acid 
phosphatase (EC 3.1.3.2) immobilized on magnetic beads. The behavior of 
native porcine pepsin A (2.8 × 10-5 mol of phosphorus per 1 g of protein), its 
partially dephosphorylated derivate (0.2 × 10-5 mol of phosphorus per 1 g of 
protein) and mixture of both (1:1) on N-acetyl-L-phenylalanine-Sepharose is 
shown in figure 3. As evident from figure 3 the phosphate group of porcine 
pepsin A participated in interaction of enzyme with N-acetyl-L-phenylalanine-
Sepharose which resulted from the retention time of both pepsin forms; 
dephosphorylated porcine pepsin A derivate had a shorter retention time than 
native form. 
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Fig. 3 Effect of dephosphorylation on porcine pepsinogen A behavior on N-acetyl-L-phenylalanine-
Sepharose 
Chromatographic conditions: I – 100 mM acetate buffer, pH 3.7; II – 100 mM acetate buffer, 
pH 3.7, containing 0.5 M NaCl; flow rate – 1 ml/min; sample – 1 ml of protein solution (1mg/ml 
100 mM acetate buffer, pH 3.7): native porcine pepsin A (blue chromatogram); partially 
dephosphorylated derivative of porcine pepsin A (green chromatogram); mixture of both forms in 
ratio 1:1 (pink chromatogram). 
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4.5. Affinity Chromatography of Human Pepsins and 
Pepsinogens 
Not much information is available on the use of affinity chromatography 
for the separation of pepsin A and pepsin C. Affinity chromatography using 
synthetic inhibitor (Val-D-Leu-Pro-Phe-Phe-Val-D-Leu) containing D-amino 
acid residues represents the only example. This inhibitor immobilized to 
Sepharose was used for the purification of human, porcine and chicken 
pepsin A, human pepsin C and bovine cathepsin D 35 and the separation of 
human pepsin A and pepsin C 32. 
Preliminary studies in our laboratory showed differences in the interaction 
of human pepsinogens with aromatic amino acids and their iodinated 
derivatives 40. In this study first, we used proteases from acidified extract of 
human gastric mucosa (pepsin A and pepsin C) and N-acetyl-L-phenylalanine-
Sepharose, 3,5-diiodo-L-tyrosine-Sepharose, iodinated-L-tyrosine-Sepharose 
(results not shown). Our results showed that these enzymes differ in their 
interaction with the immobilized aromatic acid and could be separated using 
different elution conditions. 
We mainly focused on separation of pepsins on N-acetyl-L-phenylalanine-
Sepharose, the best sorbent for pepsin A. First, model proteases (porcine 
pepsin A and rat pepsin C) were separate (fig. 4). Then we optimized the 
separation of human pepsins from human gastric juice and acidic extract of 
human stomach mucosa on N-acetyl-L-phenylalanine-Sepharose. Individual 
pepsins were identified by mass spectrometry MALDI-TOF/TOF. Fig. 5 shows 
the separation of human pepsins from gastric juice with the designation of 
individual pepsins. The pepsins were eluted in the following order: pepsin C 
(between minutes 19 and 21), mixture of pepsin A and pepsin C (between 
minutes 22 and 24) and pepsin A (between minutes 25 and 36). The recovery 
was 96%.  
Pepsinogen A and pepsinogen C from the extract of human gastric mucosa 
were separated on N-acetyl-L-phenylalanine-Sepharose (results not shown). 
Identification of individual pepsinogens was performed by non-denaturing 
polyacrylamide gel electrophoresis with staining for proteolytic activity. 
Pepsinogen A and pepsinogen C were identificated using monoclonal antibody 
against individual pepsinogens (data not shown). Partial separation of one 
pepsinogen A isozymogen was achieved. The separation of other isozymogens 
was not successful. After adjusting the pH of the collected fractions to 3.0 
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(pepsinogens converted to pepsins) the proteolytic activity was assayed. 
The recovery of pepsinogens was 91%. 
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Fig. 4 Separation of porcine pepsin A and rat pepsin C on N-acetyl-L-phenylalanine-Sepharose 
Chromatographic conditions: I – 100 mM acetate buffer, pH 3.7; II – a linear gradient of 0 – 0.5 M 
NaCl in 100 mM acetate buffer, pH 3.7 (15 min); III – 100 mM acetate buffer, pH 3.7, containing 
0.5 M NaCl; IV – 100 mM acetate buffer, pH 3.7, containing 1 M NaCl; flow rate – 1 ml/min; 
sample – 1 ml of sample solution: acidified extract of rat gastric mucosa (1.3 mg of protein/ml; 
green chromatogram); mixture of porcine pepsin A and acidified extract of rat pepsin C in a ratio 
1:1 (0.99 mg/ml; pink chromatogram); porcine pepsin A  (0.89 mg/ml; blue chromatogram). 
The identification of individual pepsins was performed by the comparison of obtained 
chromatograms. 
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Fig. 5 Separation of pepsins from human gastric juice on N-acetyl-L-phenylalanine-Sepharose 
Chromatographic conditions: I – 100 mM acetate buffer, pH 3.7; II – a linear gradient 0.1 – 0.5 M 
NaCl in 100 mM acetate buffer, pH 3.7 (30 min); III – 100 mM acetate buffer, pH 3.7, containing 
0.5 M NaCl; flow rate – 1 ml/min; sample – 1 ml of solution of lyophilized human gastric juice 
(0.679 mg protein/ml 100 mM acetate buffer, pH 3.7); (a) chromatogram with designation of 
human pepsins: blue – pepsin A; pink – mixture of both pepsin A and pepsin C; green – pepsin C; 
(b) proteolytic activity – the enzyme activity determined by the modified Anson and Mirsky 
method. 
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5. Conclusions 
 
• The following sorbents for the separation of pepsins and pepsinogens were 
prepared: iodinated L-tyrosine-Sepharose, 3,5-diiodo-L-tyrosine–
Sepharose and N-acetyl-L-phenylalanine-Sepharose. The ligands were 
immobilized to divinyl sulfone-activated Sepharose 4B either via free 
amino group or via free carboxyl group. In the case of immobilization of 
N-acetyl-L-phenylalanine or 3,5-diiodo-L-tyrosine via their free carboxyl 
groups, first ethylene diamine was linked to divinyl sulfone-activated 
Sepharose 4B and then the carbodiimide reaction was used for the coupling 
of ligand. L-tyrosine was directly immobilized to activated matrix via its 
free amino group and the resulting L-tyrosine-Sepharose was then 
iodinated using chloramine method. 
 
• Interactions of porcine pepsin A with immobilized derivatives of aromatic 
amino acids were studied. The optimum conditions for the separation of 
porcine pepsin A using the prepared affinity sorbents were found and the 
following parameters were established: enzyme recovery, reproducibility 
of analyses, capacity and dependence of the elution peak area on the 
concentration of the applied enzyme. 
 
• The ability of the prepared affinity sorbents to retain various types of 
proteins (bovine serum albumin, chicken ovalbumin, trypsin and 
α-chymotrypsin from bovine pancreas) was compared under the optimum 
conditions for porcine pepsin A separation. Out of the prepared affinity 
sorbents, the lowest non-specific interactions were observed in the case of 
N-acetyl-L-phenylalanine-Sepharose. 
 
• The interaction of porcine pepsin A active site with immobilized ligands 
was investigated. It was shown that the pepsin active site did not 
participate in interaction with immobilized ligands. The behavior of 
porcine pepsin A was the same as its complex with pepstatin A on the 
prepared affinity sorbents.  
 
• The participation of porcine pepsin A phosphate group in the interaction 
with N-acetyl-L-phenylalanine-Sepharose was investigated. It was shown 
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that pepsin phosphate group affected the interaction with N-acetyl-L-
phenylalanine-Sepharose. 
 
• All prepared affinity sorbents were used for the separation of pepsin A and 
pepsin C. Out of them, N-acetyl-L-phenylalanine-Sepharose was found to 
be the most suitable for this purpose. Using this sorbent, we were able to 
partially separate the model mixture of porcine pepsin A and rat pepsin C, 
as well as pepsins from human gastric juice and from acidified extract of 
human gastric mucosa. 
 
• The ability of immobilized ligands to interact with porcine pepsinogen A 
was investigated. Interactions of this zymogen were proved only in the 
case of N-acetyl-L-phenylalanine-Sepharose and 3,5-diiodo-L-tyrosine-
Sepharose. 
 
• N-acetyl-L-phenylalanine-Sepharose was used for the isolation of human 
 pepsinogen A and pepsinogen C from human gastric mucosa extract. In 
 addition, one of the pepsinogen A isozymogen was partially separated. 
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